Aizant Drug Research Solutions Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2005.

2005 Hyderabad, Telangana, India Active

Last Updated: February 06, 2026

About Aizant Drug Research Solutions Private Limited

Aizant Drug Research Solutions Private Limited, a active private limited company, was established on 22 November 2005 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24239TG2005PTC048133. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹26.00 Cr and a paid-up capital of ₹24.69 Cr.

Formerly known as Innodev Pharmaceuticals Private Limited. It upholds a compliant status. Employing 746 professional, Its leadership includes Tirunelveli Padmanabhan Devarajan (Director), Rudraraju Sneha (Director), Varma Rudraraju S (Managing Director). Past directors included Anurag Rastranayaka, Tirunelveli Padmanabhan Devarajan, Rudraraju Sneha. It holds ₹20.65 Cr open charges and ₹54.66 Cr settled loans. Its latest AGM occurred on 22 October 2025, with the balance sheet filed on 31 March 2025. It is based at Sy No.172 /173, Apparel Park Road, Dulapally Vil. Dundigal Gandimaisamma Mdl, Medchal - Ma, Lkajgiri,, Hyderabad, Telangana, 500100.

Company Details

CIN/LLPIN
U24239TG2005PTC048133
Registration Number
048133
Incorporation Date
22 November 2005
Authorized Capital
₹26.00 Cr
Paid-Up Capital
₹24.69 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 26.00 Cr as on 06-02-2026
Paid Up Capital ₹ 24.69 Cr as on 06-02-2026
Company Age 20 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 20.65 Cr as on 06-02-2026
Satisfied Charges ₹ 54.66 Cr as on 06-02-2026
Revenue Growth **** 13.98% (FY 2023)
Profit Growth **** 1.41% (FY 2023)
Ebitda **** -2.33% (FY 2023)
Net Worth 16.30% (FY 2023)
Total Assets **** 24.09% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Aizant Drug Research Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aizant Drug Research Solutions Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Tirunelveli Padmanabhan Devarajan	Director	27 Mar 2017	Current
Rudraraju Sneha	Director	12 Apr 2024	Current
Varma Rudraraju S	Managing Director	22 Nov 2005	Current
Sanjeev Kumar Sethi	Director	30 Sep 2024	Current
Soumya Rudraraju	Director	30 Sep 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	29 Oct 2021	Past
Pramod Abcsdd	Additional Director	27 Apr 2017	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Company Secretary	24 Nov 2017	Past
Pramod Abcsdd	Additional Director	29 Sep 2012	Past
Pramod Abcsdd	Company Secretary	01 Jan 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aizant Drug Research Solutions.

Aizant Drug Research Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.98% increase. The company also saw a slight improvement in profitability, with a 1.41% increase in profit. The company's net worth Soared by an impressive increase of 16.3%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

13.98%

*******

Revenue from Operations

*******

13.23%

*******

Total Assets

*******

24.09%

*******

Profit or Loss

*******

1.41%

*******

Net Worth

*******

16.30%

*******

EBITDA

*******

-2.33%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aizant Drug Research Solutions?

In 2023, Aizant Drug Research Solutions had a promoter holding of 47.85% and a public holding of 52.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹206,500,000.00

Satisfied Charges

₹546,600,000.00

Charges Breakdown by Lending Institutions

Others : 12.75 Cr
Hdfc Bank Limited : 5.00 Cr
State Bank Of India : 2.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Apr 2025	Hdfc Bank Limited	₹5.00 Cr	Open
30 Jun 2023	State Bank Of India	₹2.90 Cr	Open
23 Feb 2017	Others	₹12.75 Cr	Open
12 Oct 2021	Others	₹10.45 Cr	Satisfied
18 Sep 2020	Others	₹3.81 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aizant Drug Research Solutions?

Aizant Drug Research Solutions has a workforce of 746 employees as of Sep 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aizant Drug Research Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aizant Drug Research Solutions's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aizant Drug Research Solutions

Recent Activity within the Organization

Annual General Meeting

Aizant Drug Research Solutions Private Limited last Annual general meeting of members was held on 22 Oct 2025 as per latest MCA records. was recorded as a recent event.
22 Oct 2025
Charges

A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101095674 was registered on 28 Apr 2025. was recorded as a recent event.
28 Apr 2025
Balance Sheet

The activity Aizant Drug Research Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

Srinivas Kotra was appointed as a Company Secretary was appointed as a Company Secretary on 26 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
26 Dec 2024
Charges

The activity A charge registered on 18 Sep 2020 via Charge ID 100374771 with Others was fully satisfied on 25 Nov 2024. was completed.
25 Nov 2024
Director Appointment

Progress on Sanjeev Kumar Sethi was appointed as a Director was appointed as a Director on 30 Sep 2024 & has been associated with this company since 1 year 4 months . was documented.
30 Sep 2024

Explore recent activity and updates - View Recent Activity